Exploring new bacterial compounds for potential medical uses
Discovery and Biosynthesis of Bacterial Terpenoids
['FUNDING_OTHER'] · UNIVERSITY OF FLORIDA · NIH-10866428
This study is exploring how certain bacteria can create helpful natural substances called terpenoids, which might lead to new medicines, including antibiotics, to help patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF FLORIDA (nih funded) |
| Locations | 1 site (GAINESVILLE, UNITED STATES) |
| Trial ID | NIH-10866428 on ClinicalTrials.gov |
What this research studies
This research focuses on discovering new natural products derived from bacteria, specifically terpenoids, which are known for their diverse biological activities. The team will investigate the genetic and biochemical pathways that allow bacteria to produce these compounds, aiming to identify novel drug leads for medical applications. By utilizing advanced genomics and biochemistry techniques, the researchers hope to unlock the potential of these bacterial products for use in antibiotics and other therapeutic areas. Patients may benefit from new treatments developed from these discoveries.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with infections that are resistant to current antibiotic treatments.
Not a fit: Patients who do not have bacterial infections or who are not affected by antibiotic resistance may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics and therapies that are effective against various diseases.
How similar studies have performed: Previous research has shown promise in discovering new bacterial natural products, indicating that this approach could yield significant results.
Where this research is happening
GAINESVILLE, UNITED STATES
- UNIVERSITY OF FLORIDA — GAINESVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RUDOLF, JEFFREY DANIEL — UNIVERSITY OF FLORIDA
- Study coordinator: RUDOLF, JEFFREY DANIEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.